NASH Clinical Study
Boehringer Ingelheim 1404-0044
We are looking for individuals who have been diagnosed with NASH/MASH to take part in a research study for an investigational medication. The study is testing whether the investigational medication will help people with NASH/MASH who have moderate or advanced liver fibrosis.
You may qualify if:
- You are 18 years of age or older,
- Have been diagnosed with NASH/MASH with moderate or advanced liver fibrosis, and
- Are willing to maintain a stable diet and physical activity levels during participation.
Participants will receive the study medication and all related study procedures that are required at no cost. Participants may be reimbursed for travel and time commitment. To see if this study is right for you, please contact us.
Location: MNGI Digestive Health, Northeast Clinic.
Physician Investigator: Ibrahim Hanouneh, MD
Study Coordinator: Jennifer Burdick
Boehringer Ingelheim 1404-0064
MNGI Digestive Health is now enrolling patients for a new study for patients that have been diagnosed with NASH/MASH cirrhosis. This study will investigate survodutide once weekly vs. placebo on liver-related outcomes.
Participants will receive the study medication and all related study procedures at no cost to them and may be reimbursed for their time and travel. To learn more about the study and see if you may qualify for, contact us today.
Location: MNGI Digestive Health, Northeast Clinic.
Physician Investigator: Ibrahim Hanouneh, MD
Study Coordinator: Jennifer Burdick